biotech · Cholangiocarcinoma · Irritable Bowel Syndrome With Diarrhea · RDHL
RedHill Biopharma
RedHill Biopharma is a biotech organization headquartered in Raleigh, USA. It trades on NYSE under ticker RDHL. Primary therapeutic focus areas include Cholangiocarcinoma, Irritable Bowel Syndrome With Diarrhea, Coronavi
8045 Arco Corporate Drive, Suite 120, Raleigh, NC 27617, US HQ
2009 Founded
43 Employees
Public company Type
RDHL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 8045 Arco Corporate Drive, Suite 120, Raleigh, NC 27617, US
- Founded
- 2009
- Employees
- 43
- Programs
- 14
- Drugs
- 10
- Patents
- 40
Part A: Upamostat 200 mg
Phase 3 · small molecule · Covid19
Part A: Upamostat 200 mg for Covid19 is a Phase 3 program (small_molecule) at RedHill Biopharma with 1 ClinicalTrials.gov record(s).
Internal code RHB-107-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- RedHill Biopharma
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Covid19
- Status
- terminated
- Trials
- 1